Cardioneuroablation for Variant Angina

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 7, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Variant Angina
Interventions
PROCEDURE

cardioneuroablation

Participants diagnosed with medication-refractory variant angina or those unable or unwilling to take medications regularly will undergo a catheter-based cardioneuroablation (CNA) procedure. CNA targets epicardial cardiac ganglionated plexi (GP), which are clusters of autonomic ganglia involved in parasympathetic modulation of cardiac function. The procedure is designed to reduce parasympathetic overactivity contributing to coronary artery spasms. Ablation will be performed using a radiofrequency catheter to eliminate GP areas identified by anatomical landmarks and electrophysiological mapping. No control or sham procedure is included in this single-arm study.

Trial Locations (1)

430071

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhibing Lu

OTHER

NCT06992830 - Cardioneuroablation for Variant Angina | Biotech Hunter | Biotech Hunter